Product News: Ciba Vision/Leiras Betimol
Executive Summary
Ciba Vision/Leiras Betimol: Firms settle litigation with Merck involving branded version of ophthalmic beta blocker timolol and Ciba will continue to market the Leiras product under license from Merck. Leiras received a full NDA approval for timolol March 31; Merck has a patent on timolol that expires in March 1997. The three firms have agreed to dismiss pending litigation filed in Maryland federal court. Alcon received an ANDA for timolol in April; the company also obtained a license from Merck after litigation ("The Pink Sheet" May 8, 1995, T&G-16)...